From Data to Decisions: CPMAI, Governance, and Trust in Pharmaceutical AI Transformation

Abstract

From Data to Decisions: CPMAI, Governance, and Trust in Pharmaceutical AI Transformation

Table of Contents
1. Introduction: The Frontier of AI in Pharmaceuticals
2. Foundations of AI and Machine Learning in Life Sciences    
3. The CPMAI Methodology: A Framework for AI Project Success    
4. Phase 1 of CPMAI: Business Understanding and Pharma Alignment    
5. Phase 2 of CPMAI: Data Understanding in Regulated Environments    
6. Phase 3 of CPMAI: Data Preparation and Preprocessing Pipelines    
7. Phase 4 of CPMAI: Model Development and Algorithm Selection    
8. Phase 5 of CPMAI: Model Evaluation and Validation in Clinical Contexts    
9. Phase 6 of CPMAI: Deployment and Operational Monitoring    
10. AI Governance Frameworks: Managing Risk and Compliance    
11. Trust, Transparency, and Explainable AI (XAI) in Medicine    
12. Data Privacy, Security, and Ethics in Patient-Centric AI
13. AI in Drug Discovery: Accelerating Molecule to Market
14. Optimizing Clinical Trials with Intelligent Automation    
15. AI-Driven Supply Chain and Pharmacovigilance    
16. Managing the Human Element: Organizational Change and AI Literacy    
17. Case Studies in Pharmaceutical AI Failures and Successes    
18. Debates in Algorithmic Bias and Equity in Healthcare AI    
19.Future Horizons: Quantum Computing, Generative AI, and Next-Gen Pharma    
20. Conclusion: Charting the Trustworthy Path Forward    
Bibliography